Artiva Biotherapeutics, Inc. ARTV Proceeds from disposition of marketable securities and other investments
Proceeds from disposition of marketable securities and other investments at other companies
Other financials
Where this comes from
Reported directly by Artiva Biotherapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:ProceedsFromSaleMaturityAndCollectionsOfInvestments.
The official record: Artiva Biotherapeutics, Inc.’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →
Ask your AI about Artiva Biotherapeutics, Inc.'s proceeds from disposition of marketable securities and other investments.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Artiva Biotherapeutics, Inc.'s proceeds from disposition of marketable securities and other investments?
- Artiva Biotherapeutics, Inc. (ARTV) reported proceeds from disposition of marketable securities and other investments of $22M in Q1 2026.
- How has Artiva Biotherapeutics, Inc.'s proceeds from disposition of marketable securities and other investments changed year-over-year?
- Artiva Biotherapeutics, Inc.'s proceeds from disposition of marketable securities and other investments decreased by 24.1% year-over-year, from $29M to $22M.